NDC 73377-122-01 - Cromolyn sodium

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 73377-122
Requested NDC: 73377-122-01
Package NDCs from labels: 73377-122-01
Manufacturer: AX Pharmaceutical Corp
Effective date: 2021-04-05
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Cromolyn sodium - AX Pharmaceutical Corp	AX Pharmaceutical Corp	2021-04-05	BULK INGREDIENT

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
73377-122	CROMOLYN SODIUM POWDER [AX PHARMACEUTICAL CORP]	1	Unmatched	20210406_02f0019a-1636-445b-9069-8fc69d3b9e92.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 11 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
NasalCrom	CROMOLYN SODIUM	Prestige Brands Holdings, Inc.	b34d36ca-4df4-458c-af0f-c0d0c9a025d9	2026-06-03	Warnings	Exact identifier unii: Q2WXR1I0PK
Cromolyn Sodium	CROMOLYN SODIUM	Preferred Pharmaceuticals Inc.	18892411-465f-4d8d-9550-7dafa6c6a0a3	2026-04-01	Adverse reactions	Exact identifier unii: Q2WXR1I0PK
CROMOLYN SODIUM	CROMOLYN SODIUM	Omnivium Pharmaceuticals LLC	a742664b-265e-49f9-9744-d04e1fb620ae	2026-01-13	Warnings, Adverse reactions	Exact identifier unii: Q2WXR1I0PK
Cromolyn Sodium	CROMOLYN SODIUM	Sandoz Inc	b32851c3-cd97-4be4-a09c-1deab1d6966b	2025-02-20	Adverse reactions	Exact identifier unii: Q2WXR1I0PK
Cromolyn Sodium	CROMOLYN SODIUM	A-S Medication Solutions	0d30fb0a-e343-426d-8203-5816bd4cec2f	2024-11-07	Adverse reactions	Exact identifier unii: Q2WXR1I0PK
CROMOLYN SODIUM	CROMOLYN SODIUM	Micro Labs Limited	93f80edb-3b38-423e-8cd6-5b5cb4393ec2	2024-09-26	Warnings, Adverse reactions	Exact identifier unii: Q2WXR1I0PK
Gastrocrom	CROMOLYN SODIUM	Viatris Specialty LLC	00623958-a8fe-47d1-a0d2-0aa4e2f7966e	2024-06-26	Warnings, Adverse reactions	Exact identifier unii: Q2WXR1I0PK
Cromolyn Sodium	CROMOLYN SODIUM	Teva Pharmaceuticals USA, Inc.	8fe37a7a-edd6-4733-bb7e-e01c1906aeba	2023-12-14	Warnings, Adverse reactions	Exact identifier unii: Q2WXR1I0PK
CROMOLYN SODIUM	CROMOLYN SODIUM	Rising Pharma Holdings, Inc.	61c9cb85-129e-4490-b5f7-357307fcecbf	2021-08-01	Warnings, Adverse reactions	Exact identifier unii: Q2WXR1I0PK
Cromolyn Sodium	CROMOLYN SODIUM	Bausch & Lomb Incorporated	379f4b59-6866-4b5c-9b1b-d8a35b741461	2021-06-01	Warnings	Exact identifier unii: Q2WXR1I0PK
Cromolyn Sodium	CROMOLYN SODIUM	Proficient Rx LP	34ef00e8-0c01-4225-9a40-822ab245752a	2019-10-01	Adverse reactions	Exact identifier unii: Q2WXR1I0PK

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.